Winter 2015/2016 - The Innovation Highway Newsletter | Page 9
2
1
DECEMBER 2015 – JANUARY 2016
2015 GEW Medical Finalists (con’d)
InfraSonic Monitoring, Vestal, USA
InfraSonic Monitoring is a technology capable
of providing non-invasive, continuous
assessment of cardiac output suitable for
consumer use. What once was available only
in hospital or research settings will be
available to the entire community.
Symptify – Symptoms Simplified, USA
Symptify is an online self-assessment tool that
uses a customized algorithmic engine to help
users educate themselves about causes of
symptoms.
Tourniquet of Instant Gas Release, Tel Aviv,
Uri Hadelsberg is a 29 year old senior year
medical student, who has an interest in
neurosurgery, innovation and aeronautics. I
am passionate about new innovations which
can benefit the fields of neurosurgery and
medicine in particular and humanity in
general!
MediCounsel – Providing Hope, Mumbai,
India
MediCounsel is a functioning, user-friendly,
healthcare consulting portal designed to assist
the treatment of patients suffering from
complex, rare and hopeless medical
conditions.
The Tourniquet of Instant Gas Release is a
tourniquet system, which eliminates the
MGM Bio, Copenhagen, Denmark
human factor to guarantee successful use in
MGM Bio is a business-to-business
biotechnology company that provides a novel any situation. The exact and equal pressure
approach to drug discovery. It delivers natural, applied throughout the tourniquet makes this a
small molecules targeting viral diseases to the game changer in first aid situations whether it
is being used in civilian scenarios or by
pharmaceutical industry. MGM Bio
soldiers in combat service. We are currently
technology is cheaper, faster and generates
looking for investors in TIGR Tech and its
more chemical diversity than established
unique tourniquet.
methods such as combinatorial chemical
libraries and virtual molecule screening. MGM
Bio wins Venture Cup Life Science and Med
Tech 2014.
Novus Life Sciences Limited, Hong Kong
NOVUS is a biotech startup. NOVUS’s major
focus is the development of orthobiologics.
This includes the research and development of
a series of biomaterial filler formulations for
minimal invasive surgery. The profitability is
promising as the potential market of
orthobiologics is enormous and it is still
growing around the globe. email:
[email protected]
6